Begin main content

Reports

We found 5599 result(s)

halobetasol propionate and tazarotene (TBC)

Last Updated: May 31, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: halobetasol propionate and tazarotene
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: TBC
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0600-000
  • Project Status: Withdrawn
  • Submission Type: New

insulin glargine (Semglee)

Last Updated: May 31, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin glargine
Indications: Diabetes mellitus, Type 1 & 2

  • Brand Name: Semglee
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0589-000
  • Project Status: Withdrawn
  • Submission Type: New

pegfilgrastim (Fulphila )

Last Updated: May 31, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: pegfilgrastim
Indications: Febrile neutropenia in non-myeloid malignancies

  • Brand Name: Fulphila
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0588-000
  • Project Status: Complete
  • Submission Type: New

efinaconazole (Jublia)

Last Updated: June 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: efinaconazole
Indications: Onychomycosis

  • Brand Name: Jublia
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0577-000
  • Project Status: Complete
  • Submission Type: New

cysteamine (Cystadrops)

Last Updated: June 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cysteamine
Indications: Corneal cystine crystal deposits

  • Brand Name: Cystadrops
  • Manufacturer: Recordati Rare Diseases Canada Inc.
  • Project Number: SR0595-000
  • Project Status: Active
  • Submission Type: New

semaglutide (Ozempic)

Last Updated: June 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: semaglutide
Indications: Diabetes mellitus, type 2

  • Brand Name: Ozempic
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: SR0594-000
  • Project Status: Complete
  • Submission Type: New

safinamide (Onstryv)

Last Updated: June 17, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New

certolizumab pegol (Cimzia)

Last Updated: June 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: certolizumab pegol
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Cimzia
  • Manufacturer: UCB Canada Inc.
  • Project Number: SR0587-000
  • Project Status: Active
  • Submission Type: NewIndication